Literature DB >> 26625224

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

E T Wong, E Lok, S Gautam, K D Swanson.   

Abstract

Entities:  

Year:  2015        PMID: 26625224      PMCID: PMC4705903          DOI: 10.1038/bjc.2015.404

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
Correction to: Br J Cancer (2015) 113, 232–241; doi:10.1038/bjc.2015.238 Following publication of the above paper in issue 113, number 2 of the journal, the authors spotted a number of errors, two relating to Figure 1, and one relating to Table 1. There is one further typographical error in the text. On page 3, Figure 1, section 1D: the heading for the y-axis should add ‘(' before ‘cm2', as in ‘Tumor size (cm2)' Again on page 3, Figure 1, legend, lines 12–13: there is a typographical error and ‘11.2' should be ‘106.1'. The sentence should read as ‘…had a median tumor size of 4.2 (range 0.0–106.1) cm2 as compared with …'. On Table 1, under heading of Absolute T-cell subsets: ‘+' in superscript should appear after CD3, CD4 and CD8, as in ‘CD3+', ‘CD4+' and ‘CD8+'. On page 7, left column, line 2: ‘C3' should be ‘CD3'.
  11 in total

1.  Corticosteroids compromise survival in glioblastoma.

Authors:  Kenneth L Pitter; Ilaria Tamagno; Kristina Alikhanyan; Amira Hosni-Ahmed; Siobhan S Pattwell; Shannon Donnola; Charles Dai; Tatsuya Ozawa; Maria Chang; Timothy A Chan; Kathryn Beal; Andrew J Bishop; Christopher A Barker; Terreia S Jones; Bettina Hentschel; Thierry Gorlia; Uwe Schlegel; Roger Stupp; Michael Weller; Eric C Holland; Dolores Hambardzumyan
Journal:  Brain       Date:  2016-03-28       Impact factor: 13.501

2.  Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema.

Authors:  Cameron J Herting; Zhihong Chen; Victor Maximov; Alyssa Duffy; Frank Szulzewsky; Dmitry M Shayakhmetov; Dolores Hambardzumyan
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

3.  Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.

Authors:  Fan Yang; Pei Yang; Chuanbao Zhang; Yongzhi Wang; Wei Zhang; Huimin Hu; Zhiliang Wang; Xiaoguang Qiu; Tao Jiang
Journal:  Oncotarget       Date:  2017-06-27

4.  Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior.

Authors:  Maria Alieva; Andreia S Margarido; Tamara Wieles; Erik R Abels; Burcin Colak; Carla Boquetale; Herke Jan Noordmans; Tom J Snijders; Marike L Broekman; Jacco van Rheenen
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

5.  Use of statins or NSAIDs and survival of patients with high-grade glioma.

Authors:  Corinna Seliger; Julia Schaertl; Michael Gerken; Christian Luber; Martin Proescholdt; Markus J Riemenschneider; Michael F Leitzmann; Peter Hau; Monika Klinkhammer-Schalke
Journal:  PLoS One       Date:  2018-12-03       Impact factor: 3.240

Review 6.  Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.

Authors:  Ana Rita Pombo Antunes; Isabelle Scheyltjens; Johnny Duerinck; Bart Neyns; Kiavash Movahedi; Jo A Van Ginderachter
Journal:  Elife       Date:  2020-02-04       Impact factor: 8.140

7.  Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma.

Authors:  Paula Aldaz; Jaione Auzmendi-Iriarte; Maika Durántez; Irene Lasheras-Otero; Estefania Carrasco-Garcia; M Victoria Zelaya; Laura Bragado; Ana Olías-Arjona; Larraitz Egaña; Nicolás Samprón; Idoia Morilla; Marta Redondo-Muñoz; Mikel Rico; Massimo Squatrito; Marta Maria-Alonso; Joaquín Fernández-Irigoyen; Enrique Santamaria; Iñaki M Larráyoz; Claudia Wellbrock; Ander Matheu; Imanol Arozarena
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

8.  Coadministration of a Clinically Relevant Dexamethasone Dosage With Ablative Radiation Therapy Reduces Peripheral Lymphocytes But Does Not Alter In Vivo Intratumoral Lymphocyte Phenotype or Inhibit Efficacy of Radiation Therapy in a Murine Colorectal Tumor Model.

Authors:  Nicholas G Battaglia; Taylor P Uccello; Angie Hughson; Jesse Garrett-Larsen; Johnathan J Caldon; Haoming Qiu; Scott A Gerber; Edith M Lord
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-04-30       Impact factor: 8.013

9.  Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer.

Authors:  Alia Abukiwan; Clifford C Nwaeburu; Nathalie Bauer; Zhefu Zhao; Li Liu; Jury Gladkich; Wolfgang Gross; Axel Benner; Oliver Strobel; Jörg Fellenberg; Ingrid Herr
Journal:  Int J Oncol       Date:  2018-11-01       Impact factor: 5.650

10.  Dexamethasone premedication suppresses vaccine-induced immune responses against cancer.

Authors:  Mathias Vormehr; Sophie Lehar; Lena M Kranz; Siri Tahtinen; Yoko Oei; Vincent Javinal; Lélia Delamarre; Kerstin C Walzer; Mustafa Diken; Sebastian Kreiter; Ira Mellman; Ugur Sahin; Jill M Schartner; Özlem Türeci
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.